Your session is about to expire
What is Glumetza
MetforminThe Generic name of this drug
Treatment SummaryMetformin is a medication used to treat type 2 diabetes. It works by lowering blood sugar levels without causing hypoglycemia (low blood sugar). Metformin also helps reduce insulin resistance and lowers fasting insulin levels, resulting in modest weight loss. It is the drug of choice for obese type 2 diabetes patients and is used by more than 120 million people around the world. Metformin was first approved in Canada in 1972 and in the United States in 1995. It comes in regular and extended-release forms.
Metformin Hydrochlorideis the brand name
Glumetza Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Metformin Hydrochloride
Metformin
2002
1263
Approved as Treatment by the FDA
Metformin, otherwise known as Metformin Hydrochloride, is approved by the FDA for 16 uses which include Congestive Heart Failure and Physical Activity .Congestive Heart Failure
Used to treat Heart Failure in combination with Dapagliflozin
Physical Activity
Used to treat Exercise in combination with Dapagliflozin
Type 2 Diabetes
Used to treat Type 2 Diabetes Mellitus in combination with Dapagliflozin
Hospitalizations
Used to treat Hospitalizations in combination with Dapagliflozin
Diet
Used to treat Diet in combination with Dapagliflozin
Type 1 Diabetes
Used to treat Type 1 Diabetes Mellitus in combination with Sitagliptin
Chronic Kidney Disease
Used to treat Chronic Kidney Disease (CKD) in combination with Dapagliflozin
NYHA Functional Class II-IV Heart Failure
Used to treat NYHA Functional Class II-IV Heart Failure in combination with Dapagliflozin
Ejection fraction decreased
Used to treat Ejection fraction decreased in combination with Dapagliflozin
Diabetic Ketoacidosis
Used to treat Diabetic Ketoacidosis in combination with Saxagliptin
uncontrolled diabetes
Used to treat uncontrolled diabetes in combination with Rosiglitazone
Cardiovascular Disease
Used to treat Cardiovascular Risk in combination with Dapagliflozin
Cardiovascular Diseases
Used to treat established cardiovascular disease in combination with Dapagliflozin
decreased estimated glomerular filtration rate
Used to treat decreased estimated glomerular filtration rate in combination with Dapagliflozin
Cardiovascular Mortality
Used to treat Cardiovascular Mortality in combination with Dapagliflozin
Kidney Failure
Used to treat End Stage Renal Disease (ESRD) in combination with Dapagliflozin
Effectiveness
How Glumetza Affects PatientsInsulin is a hormone that helps control blood sugar levels. People with type 2 diabetes have trouble responding to insulin, which leads to higher blood sugar levels. Metformin helps reduce the amount of sugar the liver makes, stops sugar from being absorbed into the body, and makes it easier for the body to use insulin. Unlike other diabetes drugs, metformin doesn't cause the body to produce more insulin. In a study of people with type 2 diabetes, those taking metformin had their blood sugar levels drop an average of 59 mg/dL, compared to an average increase of 6.3 mg/dL in those taking a placebo
How Glumetza works in the bodyMetformin works in several ways to lower blood sugar. It reduces the amount of glucose your liver makes, blocks glucose from being absorbed by your intestines, and increases the sensitivity of your body to insulin. Metformin is taken up by liver cells, where it blocks a key enzyme and increases the ratio of AMP to ATP. This helps activate AMPK, an enzyme that regulates glucose metabolism. AMPK then stops fat synthesis and helps fat break down in the liver, making it more sensitive to insulin. Metformin also stimulates glucose metabolism in the small intestines and increases the production of GLP-1, which helps reduce
When to interrupt dosage
The suggested amount of Glumetza is contingent upon the identified condition, including Diet, inadequate response to metformin and Diabetic Ketoacidosis. The dosage changes in accordance with the mode of delivery (e.g. Oral or Tablet - Oral) noted in the table beneath.Condition
Dosage
Administration
decreased estimated glomerular filtration rate
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
Diabetic Ketoacidosis
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
Type 1 Diabetes
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
Polycystic Ovarian Syndrome
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
Congestive Heart Failure
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
Physical Activity
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
Type 2 Diabetes
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
Chronic Kidney Disease
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
Kidney Failure
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
Diet
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
Hospitalizations
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
Cardiovascular Disease
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
Cardiovascular Mortality
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
inadequate response to metformin
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
Ejection fraction decreased
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
NYHA Functional Class II-IV Heart Failure
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
Cardiovascular Diseases
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
uncontrolled diabetes
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
diet and exercise not sufficient for diabetes control
500.0 mg, , 1000.0 mg, 750.0 mg, 850.0 mg, 250.0 mg, 500.0 mg/mL, 660.0 mg, 780.0 mg
Oral, , Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit, Solution, Solution - Oral, Tablet, coated - Oral, Tablet, coated, For suspension, extended release - Oral, For suspension, extended release, Kit - Oral
Warnings
Glumetza ContraindicationsCondition
Risk Level
Notes
severe hepatic dysfunction
Do Not Combine
Impaired Renal Function
Do Not Combine
cardiovascular collapse
Do Not Combine
Diabetic Ketoacidosis
Do Not Combine
Operative Surgery
Do Not Combine
Metabolic acidosis
Do Not Combine
cardiorespiratory insufficiency caused by Heart Failure
Do Not Combine
Impaired Renal Function
Do Not Combine
kidney function unknown
Do Not Combine
Hypovolemic Shock
Do Not Combine
serum creatinine above upper limit for age range
Do Not Combine
ethanol
Do Not Combine
Acute Coryza
Do Not Combine
Hypoxemia
Do Not Combine
Liver Failure
Do Not Combine
Lactic Acidosis
Do Not Combine
Diabetic Ketoacidosis
Do Not Combine
Impaired Renal Function
Do Not Combine
estimated GFR <30mL/min
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Metformin may interact with Pulse Frequency
Common Glumetza Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The excretion of Abemaciclib can be decreased when combined with Metformin.
Procainamide
Major
The excretion of Procainamide can be decreased when combined with Metformin.
Topotecan
Major
The excretion of Topotecan can be decreased when combined with Metformin.
Abacavir
Minor
Metformin may decrease the excretion rate of Abacavir which could result in a higher serum level.
Aclidinium
Minor
Metformin may decrease the excretion rate of Aclidinium which could result in a higher serum level.
Glumetza Toxicity & Overdose RiskThe toxic dose of Metformin in rats is 1 gram/kg when given orally, 500 milligrams/kg when given through the abdomen, and 300 milligrams/kg when given through the skin. Similarly, in mice, the toxic dose is 1,450 milligrams/kg when given orally, 420 milligrams/kg when given through the abdomen, and 225 milligrams/kg when given through the skin. Metformin decreases the liver's uptake of lactate, which can lead to lactic acidosis in rare cases. Risk factors for metformin-associated lactic acidosis include kidney problems
Glumetza Novel Uses: Which Conditions Have a Clinical Trial Featuring Glumetza?
At present, 346 active clinical trials are investigating Glumetza's capacity to treat Type 2 Diabetes, Type 1 Diabetes and an inadequate response to metformin treatments.Condition
Clinical Trials
Trial Phases
inadequate response to metformin
0 Actively Recruiting
Type 2 Diabetes
192 Actively Recruiting
Phase 2, Not Applicable, Early Phase 1, Phase 1, Phase 4, Phase 3
Chronic Kidney Disease
112 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 4, Phase 3, Early Phase 1
Cardiovascular Disease
30 Actively Recruiting
Not Applicable, Phase 1, Early Phase 1, Phase 3, Phase 2
Polycystic Ovarian Syndrome
9 Actively Recruiting
Phase 1, Not Applicable, Phase 2, Phase 3, Early Phase 1, Phase 4
Type 1 Diabetes
144 Actively Recruiting
Phase 3, Phase 1, Early Phase 1, Not Applicable, Phase 2, Phase 4
Diabetic Ketoacidosis
3 Actively Recruiting
Phase 2, Early Phase 1, Not Applicable
decreased estimated glomerular filtration rate
0 Actively Recruiting
Kidney Failure
54 Actively Recruiting
Phase 3, Phase 1, Phase 2, Phase 4, Not Applicable
Congestive Heart Failure
313 Actively Recruiting
Phase 2, Phase 3, Not Applicable, Phase 1, Early Phase 1, Phase 4
Diet
5 Actively Recruiting
Not Applicable
uncontrolled diabetes
0 Actively Recruiting
NYHA Functional Class II-IV Heart Failure
0 Actively Recruiting
Ejection fraction decreased
0 Actively Recruiting
Hospitalizations
2 Actively Recruiting
Not Applicable
Cardiovascular Diseases
0 Actively Recruiting
Physical Activity
38 Actively Recruiting
Not Applicable, Phase 2, Phase 1, Early Phase 1
Cardiovascular Mortality
0 Actively Recruiting
diet and exercise not sufficient for diabetes control
0 Actively Recruiting
Glumetza Reviews: What are patients saying about Glumetza?
5Patient Review
5/6/2013 I took 1 500mg pill for 2 days and had the worst nausea, gas and stomach pains!!! I can't take it again. Had a similar, but less severe experience with Metformin ER.
5Patient Review
3/19/2014 Switching to gourmet metformin from regular helped me a lot with my diarrhea problem. As long as I eat minimal amounts of carbs, it works great with no side effects. If I don't get enough or the right kind of carbs, though, I have some nasty gastric issues.
5Patient Review
10/16/2013 Glumetza ER has alleviated the severe diarrhea I was experiencing with base Glumetza. 1000mg twice a day (morning and night) is my current dosage.
5Patient Review
10/29/2015 I was on Metformin (2 x 500 mg per day) for 4 1/2 years. Gradually, nausea and heartburn started and increased until they were unbearable. I learned about Glumetza 1000 mg and started it in April 2015; the side effects disappeared within a few days.
5Patient Review
5/12/2016 Glumetza was great for my stomach, but unfortunately didn't help lower my blood sugar as much. The cost increase was also a big factor in why I had to switch back to Metformin.
4.3Patient Review
4/21/2013 I was taking this medication for five weeks, but I'm quitting today because it made me too anxious.
4.3Patient Review
8/13/2015 Glumetza has been the best for my stomach, but it is way too expensive. I've been spending $353/month and it just jumped to over $3000!
3.7Patient Review
1/19/20133.7Patient Review
8/9/2014 Glumetza 500XR has worked much better for me than Metformin 1000mg. I no longer experience gas or gastric issues, and my neuropathy pain has decreased significantly.
3Patient Review
4/13/2013 I had a really bad experience with this drug. I was taking generic Metformin and my doctor switched me to the name brand Glumetza in an effort to stop the diarrhea I was experiencing. Once I paid $800 for a month supply and gave it a try, the diarrhea got even worse!
3Patient Review
4/27/2013 I gained weight while on this medication, which was frustrating. Additionally, it didn't do much to help control my blood sugar levels. Finally, the cost of the medication was quite high.
3Patient Review
11/14/2014 My blood sugar isn't as low as it used to be, but this treatment is still helpful.
2.7Patient Review
9/14/2013 This medication unfortunately gave me diarrhea, itching, and blisters.
2.3Patient Review
4/5/2013 This was working well for me at first, but it's not effective anymore. My blood sugar is now over 200 when I fast.
2.3Patient Review
7/19/2013 Metformin made me so sick that I couldn't keep food down. In contrast, this pill didn't have any adverse reactions for me and I actually lost 5 pounds in the first month without changing anything else. The only downside is that it's SO expensive.
2Patient Review
12/17/20121Patient Review
8/26/2013 My insulin levels were really high when I took this medication, way higher than what the doctor wanted. The side effects were also really bad - stomach aches and diarrhea - and made me feel weak and tired.
1Patient Review
3/8/2013 This drug is expensive and unfortunately ineffective for me.
Patient Q&A Section about glumetza
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is Glumetza?
"The medication GLUMETZA, which is an extended release tablet of metformin hydrochloride, is used to help manage type 2 diabetes. This medication is not related chemically or pharmacologically to any other classes of oral antihyperglycemic agents."
Answered by AI
Why is Glumetza better than metformin?
"Compared to metformin immediate-release doses that are equal in strength, using Glumetza results in the same amount of the drug being distributed throughout the body. However, the peak plasma concentration will be 35% higher. When doses of Glumetza ranging from 500 mg to 2500 mg were given, the total drug exposure and peak plasma concentration increased, but not in proportion to the dose."
Answered by AI
Is Glumetza the same as metformin?
"Glumetza is a MOD metformin product that uses Acuform and Smartcoat, two advanced delivery systems. These delivery systems contain a substance that allows the metformin tablet to stay in the stomach for an extended period of time."
Answered by AI
What is Glumetza used for?
"The drug is used to treat patients with type 2 diabetes by controlling high blood sugar levels, which can prevent complications such as kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke."
Answered by AI